- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Preop MRI Recommended for All New Breast Cancer Patients
Preoperative MRIs should be done on all newly diagnosed breast cancer patients, regardless of breast density.
Preoperative MRIs should be done on all newly diagnosed breast cancer patients, regardless of breast density, say researchers from Yale University School of Medicine in New Haven. The results of their study were presented at the American Roentgen Ray Society Annual Meeting in Vancouver, Canada.
Preop MRIs are ordered more often for young women or those who have dense breasts, said Reena Vashi, MD, one of the study authors. However, researchers studied 127 patients to determine if 3T MRI could be of use preoperatively in detecting additional malignancies - regardless of age or breast tissue density.
The researchers found that preop MRIs detected additional malignancies in 26 percent of patients whose breasts were not considered dense and in 25 percent of patients with dense breast tissue. There were no differences between the groups regarding the sizes or distribution of the lesions.
In addition, there were several patients who had unsuspected additional cancers in the opposite breast or in a separate quadrant from the known cancer in the affected breast, the researchers discovered.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
